Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Virologic Response”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableStudy completedNCT03500172
What this trial is testing

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

Who this might be right for
HIV-1 Virologic Response
Johns Hopkins Bloomberg School of Public Health 1,391
Early research (Phase 1)Study completedNCT00051818
What this trial is testing

Immune and Viral Outcomes of HIV-1 Therapy Interruption

Who this might be right for
HIV Infections
The Wistar Institute 20
Early research (Phase 1)Study completedNCT00270465
What this trial is testing

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 17
Not applicableUnknownNCT00069485
What this trial is testing

Resistance to HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)WithdrawnNCT00686270
What this trial is testing

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Who this might be right for
HIV Infections
Avexa
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Large-scale testing (Phase 3)Study completedNCT01060618
What this trial is testing

Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short Term

Who this might be right for
HIV Infections
Asociacion para el Estudio de las Enfermedades Infecciosas 58
Early research (Phase 1)Study completedNCT03570918
What this trial is testing

MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1-infection
MacroGenics 21
Large-scale testing (Phase 3)Study completedNCT00966160
What this trial is testing

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
University of Cologne 215
Early research (Phase 1)Study completedNCT02208167
What this trial is testing

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

Who this might be right for
HIV
University of North Carolina, Chapel Hill 6
Early research (Phase 1)Study completedNCT00002403
What this trial is testing

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

Who this might be right for
HIV Infections
Aronex Pharmaceuticals 12
Not applicableStudy completedNCT01346878
What this trial is testing

Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment

Who this might be right for
HIV
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 143
Testing effectiveness (Phase 2)Study completedNCT00085917
What this trial is testing

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Study completedNCT00018031
What this trial is testing

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Post-approval studies (Phase 4)Study completedNCT00615745
What this trial is testing

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla

Who this might be right for
HIV Infections
Gilead Sciences 115
Not applicableStudy completedNCT03251690
What this trial is testing

Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression

Who this might be right for
Anti-Retroviral AgentsEfavirenzHIV-1-infection+3 more
Mahidol University 246
Large-scale testing (Phase 3)Study completedNCT01448707
What this trial is testing

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Who this might be right for
Human Immunodeficiency Virus (HIV) InfectionsAcquired Immunodeficiency Syndrome (AIDS) Virus
Janssen-Cilag International NV 274
Early research (Phase 1)Study completedNCT03485963
What this trial is testing

HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals

Who this might be right for
HIV Infections
Catherine Bollard 7
Not applicableStudy completedNCT04147325
What this trial is testing

Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

Who this might be right for
HIV
Janssen-Cilag Farmaceutica Ltda. 105
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Load More Results